Monumental day to be a co-author of the EARLY TAVR trial published in NEJM today! The results will change our practice in asymptomatic severe AS.
Thank you to Philippe Genereux for leading the trial and presenting the late-breaker today.
Kashish Goel
3,145 posts
Kashish Goel
@kashishgoelmd
Director, Transcatheter Heart Valve Interventions, Vanderbilt @VUMC_heart. Associate Professor of Medicine; Opinions are my own and not the views of my employer
- Want to know the outcomes of MitraClip in secondary MR since FDA approval? Come join me at #ESC2022 where I will be presenting the COAPT Post Approval Study as a Late-Breaker on Aug 28 @PaulMahoneyMD @PradeepYadavMD @_WayneBatchelor @JasonHRogersMD @colinbarkerMD @ESC_Journals
- Excited to announce that I have been appointed as the Director of Transcatheter Heart Valve Interventions, Vanderbilt University Medical Center. Thanks to @colinbarkerMD, @ChetRihal #Brian Lindman @JaneFreedmanMD for the support and opportunities
- Absolutely thrilled and honored to be named a finalist for the 2024 TCT Linnemeier Interventional Cardiology Award!! Only thing I can say is that dreams do come true and hard work pays off. Immense gratitude to my family, mentors, and incredible patients for their unwavering
- Our team at Vanderbilt performed the World's first case of InnoValve TMVR larger valve size! Incredibly proud of our amazing Valve, Research, Cath lab, Imaging and Anesthesia teams! Thanks to @ChetRihal and InnoValve @colinbarkerMD
- The COAPT Post Approval Study is out in @JACCJournals today! Real world data on 5000 SMR patients treated with MitraClip at 406 sites showed that it was safe and effective. Free download available at this link for next 50 days: authors.elsevier.com/a/1hnDt2d9GHwW…
- Absolutely thrilled to have been accepted for the prestigious SCAI ELM (Emerging Leader Mentorship) program. This is the honor of a lifetime!! Heartfelt thanks to @scaielm @SrihariNaiduMD @georgedangas @psorajja @colinbarkerMD @ChetRihal @nidhiguptatweet @crfheart @ACCinTouch
- Interested in the outcomes of TAVR in cardiogenic shock with contemporary balloon-expandable valves? Our updated TVT registry analysis was just published in European Heart Journal today. My 1st first author publication in EHJ!! academic.oup.com/eurheartj/arti… @Dhoble7 @ehj_ed
- I’m truly honored to be a finalist for the Linnemeier Award at #TCT2024! Celebrating this moment with my incredible team from Vanderbilt made it even more special. Huge congratulations to the winners, Alex and Robert! Dr. Linnemeier was a legend in interventional cardiology, and
- Great cases of Shockwave IVL @VUMC_heart this week. This is a game changer for calcified lesions. Ostial RCA lesion - 3.0 NC wouldn’t expand at 24 atm. After 60 pulses of IVL, full expansion and then stent. No need to change the wire or guide. @colinbarkerMD @ShockwaveIVL
00:00 - Honored to share the stage with Dr. Sorajja and present a late-breaker at the same time! ESC 2022 has been an unforgettable experience #ESCCongress @escardio @Steph_Achenbach @vonBardelebenRS @psorajja @EAPCIPresident Now some Barcelona time..beautiful city!
- GALLILEO trial - Rivaroxaban in TAVR pts stopped early because of harm. Didn’t hear anything about this until today @willsuh76 @rajivxgulati @SVRaoMD @GreggWStone @Drroxmehran @PradeepYadavMD @ekgpdx @DrArgyle @DLBHATTMD @jtsaxon @HeartOTXHeartMD @TCTMD_Yael @CMichaelGibson
- Honored to be selected for the 2024 ACC Emerging Faculty Program! Looking forward to learning from the masters! @VUMC_Medicine @aelsab @HamidNadira @ACCinTouch @scaielm @SCAI @crfheart @Pooh_Velagapudi
